Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine adjuvant in supraclavicular block
NCT04981951Unknown
- Start
- Oct 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in pain (2 arms). Primary endpoints: The onset of anaesthesia in supraclavicular plexus block up to 9 hours and The duration of anesthesia in supraclavicular plexus block up to 9 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04981951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04981951.